These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6339093)

  • 21. Hemorrheological abnormalities in different states of diabetic retinopathy. Effect of metabolic control and subsequent diseases.
    Volger E
    Bibl Anat; 1979; (18):60-6. PubMed ID: 496881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mean retinal circulation time as determined by fluorescein angiography in normal, prediabetic, and chemical-diabetic subjects.
    Soeldner JS; Christacopoulos PS; Gleason RE
    Diabetes; 1976; 25(2 SUPPL):903-8. PubMed ID: 971794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.
    De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Thromb Haemost; 1984 Jul; 51(3):313-6. PubMed ID: 6495252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific thromboxane synthetase inhibition and retinopathy in insulin-dependent diabetics.
    Barnett AH; Armstrong S; Wakelin K; Leatherdale BA; Chisholm I; Thorogood P
    Diabetes Res; 1986 Mar; 3(3):131-4. PubMed ID: 3519046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erythrocyte and platelet parameters and degree of control of diabetes].
    Juhan-Vague I; Vague P
    Nouv Rev Fr Hematol (1978); 1982; 24(3):191-5. PubMed ID: 6752881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of angiography with disodium fluorescein on the hemorheologic parameters of diabetics].
    Sargento L; Zabala L; Gomes T; Saldanha C; Martins-Silva J; Souza-Ramalho P
    Acta Med Port; 1996; 9(10-12):303-7. PubMed ID: 9254526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoxsuprine in nonproliferative diabetic retinopathy: effect on human retinal circulation assessed by fluorescein angiography--a pilot study.
    Dandrieu MR; Brood-van Zanten MM
    Angiology; 1991 Feb; 42(2):140-5. PubMed ID: 2006758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retinal circulation and pathological change studied by fluorescein photography].
    Mizobe A
    Ganka; 1966 Feb; 8(2):139-51. PubMed ID: 6006637
    [No Abstract]   [Full Text] [Related]  

  • 31. [Microcirculation disturbances at the onset of diabetic retinopathy. New therapeutic procedures? (author's transl)].
    Jütte A; Deufrains A; Dietze U
    Klin Monbl Augenheilkd; 1980 Jul; 177(1):1-6. PubMed ID: 7005511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Platelet functions in diabetes with angiopathy (author's transl)].
    Dupuy E; Guillausseau PJ; Gaudeul P; Kartalis G; Wild AM; Pastureau A; Soria C; Malbec D; Duprey J; Lubetzki J; Caen JP
    Nouv Presse Med; 1979 Oct; 8(39):3123-5. PubMed ID: 537870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of "Ticlid" in treatment of diabetic retinopathy].
    Mirkiewicz-Sieradzka B; Kostka-Trabka E; Romanowska B; Zygulska-Mach H; Bieroń K; Szpakowicz U; Orzechowska G
    Klin Oczna; 1995; 97(7-8):244-7. PubMed ID: 8531458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemorheological factors and metabolic parameters in a group of diabetic subjects].
    Caimi G; Catania A; Frazzetta F; Giardina E; Triolo G; Sarno A
    Arch Sci Med (Torino); 1981; 138(3):299-306. PubMed ID: 7032462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute panendothelial retinal leakage in juvenile diabetes (author's transl)].
    Bonnet M; Bensoussan B; Grange JD; Pingault C; Francoz N
    J Fr Ophtalmol; 1982; 5(5):303-16. PubMed ID: 7050224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [181 cases of retinopathy in diabetics].
    Luo CR
    Zhonghua Yi Xue Za Zhi; 1985 Apr; 65(4):235-9. PubMed ID: 3924366
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemorheological background of acetylsalicylic acid resistance.
    Feher G; Koltai K; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variations in platelet aggregability in non insulin dependent diabetes patients (NIDDM).
    Spanò GM; La Mancusa R; Pettirossi G; Pulcinelli FM; Gazzaninga PP; Cordova C
    Clin Ter; 1993 Jan; 142(1):19-22. PubMed ID: 8472505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of propofol on erythrocyte morphology, blood viscosity and platelet function.
    Reinhart WH; Felix Ch
    Clin Hemorheol Microcirc; 2003; 29(1):33-40. PubMed ID: 14561902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.